loadpatents
Patent applications and USPTO patent grants for Loibner; Hans.The latest application filed is for "preparations and methods for treating a gd2 positive cancer".
Patent | Date |
---|---|
Method for treating a GD2 positive cancer Grant 11,447,565 - Loibner , et al. September 20, 2 | 2022-09-20 |
Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples Grant 11,079,398 - Poglitsch , et al. August 3, 2 | 2021-08-03 |
Preparations And Methods For Treating A Gd2 Positive Cancer App 20210221909 - LOIBNER; Hans ;   et al. | 2021-07-22 |
Preparations and methods for treating a GD2 positive cancer Grant 10,995,147 - Loibner , et al. May 4, 2 | 2021-05-04 |
Preparations And Methods For Treating A Gd2 Positive Cancer App 20200332021 - LOIBNER; Hans ;   et al. | 2020-10-22 |
Method for producing ACE2 polypeptide Grant 10,716,833 - Schuster , et al. | 2020-07-21 |
Method for Treating a GD2 Positive Cancer App 20200055953 - Loibner; Hans ;   et al. | 2020-02-20 |
Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases Grant 10,472,341 - Ermann , et al. Nov | 2019-11-12 |
Method for treating a GD2 positive cancer Grant 10,294,305 - Loibner , et al. | 2019-05-21 |
Method Of Treating Lung, Kidney, Or Heart Disease With A Recombinant Ace2 Polypeptide Dimer App 20180289779 - Schuster; Manfred ;   et al. | 2018-10-11 |
Preparations And Methods For Treating A Gd2 Positive Cancer App 20180258183 - LOIBNER; Hans ;   et al. | 2018-09-13 |
Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System App 20180200330 - POGLITSCH; Marko ;   et al. | 2018-07-19 |
Bicyclic Tetrahydrothiazepine Derivatives Useful For The Treatment Of Neoplastic And/or Infectious Diseases App 20180170888 - ERMANN; Monika ;   et al. | 2018-06-21 |
Method For Treating A Gd2 Positive Cancer App 20180134801 - LOIBNER; Hans ;   et al. | 2018-05-17 |
Treatment Of Inflammatory Illnesses With Ace2 App 20180117126 - LOIBNER; Hans ;   et al. | 2018-05-03 |
Compositions and methods for the treatment of diseases related to the renin-angiotensin-system Grant 9,839,668 - Poglitsch , et al. December 12, 2 | 2017-12-12 |
Preparations and methods for treating a GD2 positive cancer Grant 9,840,566 - Loibner , et al. December 12, 2 | 2017-12-12 |
Method For Measurement Of Peptidic Degradation Products Of A Proteolytic Cascade In Blood Samples App 20170285048 - Poglitsch; Marko ;   et al. | 2017-10-05 |
Method for treating a GD2 positive cancer Grant 9,777,068 - Loibner , et al. October 3, 2 | 2017-10-03 |
Modified ACE2 polypeptides Grant 9,757,433 - Loibner , et al. September 12, 2 | 2017-09-12 |
Method for measurement of peptidic degradation products of a proteolytic cascade in blood samples Grant 9,684,004 - Poglitsch , et al. June 20, 2 | 2017-06-20 |
Treatment of inflammatory illnesses with ACE2 Grant 9,561,263 - Loibner , et al. February 7, 2 | 2017-02-07 |
Compositions and Methods for the Treatment of Diseases Related to the Renin-Angiotensin-System App 20160310562 - POGLITSCH; Marko ;   et al. | 2016-10-27 |
Preparations and Methods for Treating a GD2 Positive Cancer App 20160304620 - LOIBNER; Hans ;   et al. | 2016-10-20 |
Combination Of Tumor-associated Surface Protein Antigens And Tumor-associated Sugars In The Treatment And Diagnosis Of Cancer App 20160000914 - LOIBNER; Hans ;   et al. | 2016-01-07 |
Modified ACE2 polypeptides App 20150353910 - LOIBNER; Hans ;   et al. | 2015-12-10 |
SiRNA against Cbl-b and optionally IL-2 and IL-12 for use in the treatment of cancer Grant 9,186,373 - Lametschwandtner , et al. November 17, 2 | 2015-11-17 |
Sirna Against Cbl-b And Optionally Il-2 And Il-12 For Use In The Treatment Of Cancer App 20150313931 - Lametschwandtner; Gunther ;   et al. | 2015-11-05 |
Method for Tretaing a GD2 Positive Cancer App 20150139942 - Loibner; Hans ;   et al. | 2015-05-21 |
Method for Measurement of Peptidic Degradation Products of a Proteolytic Cascade in Blood Samples App 20150050676 - Poglitsch; Marko ;   et al. | 2015-02-19 |
Treatment of tumors Grant 8,946,162 - Janzek-Hawlat , et al. February 3, 2 | 2015-02-03 |
Compositions for Preventing or Treating Adverse Reactions of EGFR Inhibition App 20140322308 - Loibner; Hans ;   et al. | 2014-10-30 |
Method for increasing immunoreactivity Grant 8,809,288 - Baier , et al. August 19, 2 | 2014-08-19 |
Method for Treating a GD2 Positive Cancer App 20140170155 - Loibner; Hans ;   et al. | 2014-06-19 |
Ace2 Polypeptide App 20140099297 - Schuster; Manfred ;   et al. | 2014-04-10 |
Sirna Against Cbl-b And Optionally Il-2 And Il-12 For Use In The Treatment Of Cancer App 20140010781 - Lametschwandtner; Gunther ;   et al. | 2014-01-09 |
Recombinant ACE2 polypeptide dimer Grant 8,586,319 - Schuster , et al. November 19, 2 | 2013-11-19 |
Use of antibodies for the vaccination against cancer Grant 8,444,974 - Eckert , et al. May 21, 2 | 2013-05-21 |
Method of treating lewis Y-expressing tumors Grant 8,323,650 - Schuster , et al. December 4, 2 | 2012-12-04 |
Method for determining ACE2 activity Grant 8,241,864 - Loibner , et al. August 14, 2 | 2012-08-14 |
Polysaccharide-polypeptide conjugate Grant 8,153,135 - Loibner , et al. April 10, 2 | 2012-04-10 |
Method for Determining the Cbl-b Expression App 20120040864 - Loibner; Hans ;   et al. | 2012-02-16 |
Use Of Antibodies For The Vaccination Against Cancer App 20120003232 - ECKERT; Helmut ;   et al. | 2012-01-05 |
Cancer immunotherapy predictive parameters Grant 8,062,625 - Loibner November 22, 2 | 2011-11-22 |
Immunogenic recombinant antibody Grant 8,034,338 - Loibner , et al. October 11, 2 | 2011-10-11 |
Treatment Of Tumors App 20110033524 - Janzek-hawlat; Evelyne ;   et al. | 2011-02-10 |
Treatment Of Inflammatory Illnesses With Ace2 App 20110020315 - Loibner; Hans ;   et al. | 2011-01-27 |
N-glycosylated Antibody App 20110020331 - Schuster; Manfred ;   et al. | 2011-01-27 |
Treatment Of Fibroses And Liver Disorders App 20100316624 - Loibner; Hans ;   et al. | 2010-12-16 |
ACE2 Polypeptide App 20100310546 - Schuster; Manfred ;   et al. | 2010-12-09 |
Immunogenic, Monoclonal Antibody App 20100310551 - LOIBNER; Hans ;   et al. | 2010-12-09 |
Method for Determining ACE2 Activity App 20100261214 - Loibner; Hans ;   et al. | 2010-10-14 |
Method for Increasing Immunoreactivity App 20100260808 - Baier; Gottfried ;   et al. | 2010-10-14 |
Use Of Antibodies For The Vaccination Against Cancer App 20100233178 - ECKERT; Helmut ;   et al. | 2010-09-16 |
N-glycosylated antibody Grant 7,759,464 - Schuster , et al. July 20, 2 | 2010-07-20 |
Cancer Immunotherapy Predictive Parameters App 20100086570 - Loibner; Hans | 2010-04-08 |
Use of antibodies for the vaccination against cancer Grant 7,691,372 - Eckert , et al. April 6, 2 | 2010-04-06 |
General Prognostic Parameters For Tumour Patients App 20100028932 - Loibner; Hans | 2010-02-04 |
Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant Grant 7,615,226 - Loibner , et al. November 10, 2 | 2009-11-10 |
Use Of A Preparation Based On An Antibody Directed Against A Tumor-associated Glycosylation App 20090181030 - LOIBNER; Hans ;   et al. | 2009-07-16 |
Combination Of Tumor-associated Surface Protein Antigens And Tumor-associated Sugars In The Treatment And Diagnosis Of Cancer App 20090130125 - LOIBNER; Hans ;   et al. | 2009-05-21 |
Use of a preparation based on an antibody directed against a tumor-associated glycosylation Grant 7,527,789 - Loibner , et al. May 5, 2 | 2009-05-05 |
N-Glycosylated Antibody App 20080095783 - Schuster; Manfred ;   et al. | 2008-04-24 |
Immunogenic Recombinant Antibody App 20070258978 - Loibner; Hans ;   et al. | 2007-11-08 |
Method for Selecting Epitopes for Immunotherapy App 20070243201 - Loibner; Hans ;   et al. | 2007-10-18 |
Use Of Antibodies For The Vaccination Against Cancer App 20070224202 - ECKERT; Helmut ;   et al. | 2007-09-27 |
Immunotherapy of rectal cancer App 20060246056 - Loibner; Hans ;   et al. | 2006-11-02 |
Use of antibodies against tumor-associated antigen App 20060127403 - Loibner; Hans ;   et al. | 2006-06-15 |
Polysaccharide-polypeptide conjugate App 20060062796 - Loibner; Hans ;   et al. | 2006-03-23 |
Use of antibodies in a very low dose for the vaccination against cancer App 20060018901 - Loibner; Hans ;   et al. | 2006-01-26 |
Combination of tumor-associated surface protein antigens and tumor-associated sugars in the treatment and diagnosis of cancer App 20050255116 - Loibner, Hans ;   et al. | 2005-11-17 |
Polysaccharide-polypeptide conjugate Grant 6,956,119 - Loibner , et al. October 18, 2 | 2005-10-18 |
Use of a preparation based on an antibody directed against a tumor-associated glycosylation App 20050226880 - Loibner, Hans ;   et al. | 2005-10-13 |
Immunogenic monoclonal antibody App 20050181475 - Loibner, Hans ;   et al. | 2005-08-18 |
Use of a vaccine for active immunization against cancer App 20050169929 - Himmler, Gottfried ;   et al. | 2005-08-04 |
Monoclonal antibodies and their use App 20050163768 - Eckert, Helmut ;   et al. | 2005-07-28 |
Use of antibodies for the vaccination against cancer App 20040265318 - Eckert, Helmut ;   et al. | 2004-12-30 |
Method for producing a vaccine App 20040191242 - Himmler, Gottried ;   et al. | 2004-09-30 |
Use of polyclonal immunoglobulins App 20040151717 - Loibner, Hans ;   et al. | 2004-08-05 |
Method for producing vaccines containing a heat-treated mixture consisting of at least one antigen and of at least one adjuvant App 20030143221 - Loibner, Hans ;   et al. | 2003-07-31 |
Polysaccharide-polypeptide conjugate App 20030120033 - Loibner, Hans ;   et al. | 2003-06-26 |
Monoclonal antibodies and their use App 20020146410 - Eckert, Helmut ;   et al. | 2002-10-10 |
Humanized antibodies that recognize difucosyl Lewis blood group antigens Y-6 and B-7-2 Grant 5,562,903 - Co , et al. October 8, 1 | 1996-10-08 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.